The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
Stephen John ClarkeMatthew BurgeKynan FeeneyPeter GibbsKristian JonesGavin MarxMark P MolloyTimothy PriceWilliam H H ReeceEva SegelovNiall C TebbuttPublished in: PloS one (2020)
ClinicalTrials.gov: NCT01588990; posted May 1, 2012.
Keyphrases